Barr's Generic Prozac Will Be Launched By October Following Appeal Victory
Barr expects to launch its generic fluoxetine before October, the company said, following a federal appellate court decision upholding its patent challenge to Lilly's Prozac.
Barr expects to launch its generic fluoxetine before October, the company said, following a federal appellate court decision upholding its patent challenge to Lilly's Prozac.